BIOLASE (NASDAQ:BIOL) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL – Get Rating) in a research report report published on Wednesday. The brokerage issued a sell rating on the medical technology company’s stock. Separately, Lake Street Capital reissued a buy rating on shares of BIOLASE in a research report on Friday, January 20th. BIOLASE Trading Down 7.0 […]

Related Keywords

,Capital Wealth Alliance ,Biolase Inc ,Renaissance Technologies ,Essex Investment Management Co ,Nasdaq ,Perkins Capital Management Inc ,Armistice Capital ,Get Rating ,Lake Street Capital ,Investment Management ,Capital Management ,Biolase ,Nasdaq Biol ,Fbiol ,Medical ,Initiated Coverage ,Stocknews Com ,